Correlation of Campbell Score With Suicidal Ideation

Status unconfirmed

Conditions studied: Suicidal Ideation

In brief

The Campbell Score is a blood based means of assessing molecules believed to be associated with suicidal ideation and in some cases successful suicide. The current clinical trial will assess the Campbell Score in 3 groups: Group 1: 10 patients with no personal or family psychiatric history and no suicide attempts. Group 2: 10 patients with suicidal ideation (Hamilton Depression Rating Scale suicide item \>2) and reported low acquired capability for suicide (Acquired Capability for Suicide Scale \<20). Group 3: 10 patients with suicidal ideation (Hamilton Depression Rating Scale suicide item \>2) and reported high acquired capability for suicide (Acquired Capability for Suicide Scale \>60). The goal of the study is to confirm efficacy of Campbell Score in identifying patients with high suicidal ideation potential.

Key facts

Study ID

NCT04606875

Run by

Therapeutic Solutions International

People needed

30

Starts

2020-11-05

Expected to finish

2021-02-13

Last updated by the study team

2020-10-28

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Capability of giving informed consent
• Agree to abide by the study protocol and its restrictions and be able to complete all aspects of the study.
• Be diagnosed with Suicide ideation/attempts/gestures

You may not qualify if…

• Not currently pregnant or lactating (due to potential confounding of brain activity as a result of differing hormone levels)

Where it is running

• Therapeutic Solutions International — Oceanside, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.